If you have aortic regurgitation, the flaps around your aortic valve — the valve that pumps blood to your heart — don’t close fully. This causes blood to leak back into your left heart chamber.

Aortic valve disease is a disease where that the valve which is located between the heart and the aorta is not ... "In our study, we have identified a model of mechanical aortic valves which ...

The split is due to the significantly delayed closure of the aortic valve resulting from the increased time needed to complete LV systole; for more on splitting of S2, see Heart Sounds Topic Review.

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

As mentioned previously, medically managed treatment of severe aortic stenosis has a dismal prognosis, with an overall mean survival of 3 years from the onset of symptoms. [11,12] Surgical valve ...

CHICAGO, IL—High-risk older patients with a history of heart failure (HF) who are undergoing transcatheter aortic valve implantation have better outcomes when taking dapagliflozin, results from the ...

The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies.

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.